Compounders Sue FDA; Young Women in Perimenopause; More Osteoporosis Biosimilars

MedPage Today) — A group representing compounding pharmacies sued the FDA over the removal of semaglutide (Ozempic, Wegovy) from the agency’s drug shortage list. (The Hill)
Investigational pilavapadin — an oral, non-opioid adaptor-associated…